LARGE B-CELL LYMPHOMA (LBCL)
Clinical trials for LARGE B-CELL LYMPHOMA (LBCL) explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA (LBCL) trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA (LBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lymphoma: three-drug combo enters early trials
Disease control Not yet recruitingThis early-phase trial tests a combination of three drugs (golcadomide, poseltinib, and rituximab) in 20 adults with relapsed or refractory large B-cell lymphoma. The goal is to see if the combination can shrink or eliminate tumors. Participants must have tried other treatments f…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Experimental CAR-T therapy targets tough lymphoma in small safety trial
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy (CD19X) in 3 people with relapsed or refractory large B-cell lymphoma, a blood cancer that has not responded to standard treatments. The main goal is to check safety, looking for side effects like cytokine release synd…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:57 UTC